Cinda Bio-Pharmaceutical (Suzhou) Co., Ltd. was established on August 24, 201/,and its business scope includes providing research and development, pilot test, technology transfer, and related technical consultation and technical services for antibody drugs and protein drugs. Committed to being the best and world-class high-end biopharmaceutical pharmaceutical company in China, and researching and producing high-end biopharmaceuticals that ordinary people can afford. The company has obtained the investment of 490 million US dollars from world-renowned venture capitalists, forming a new pattern of using global capital to support innovation.